Esperion Therapeutics (ESPR)
(Delayed Data from NSDQ)
$2.08 USD
+0.02 (0.97%)
Updated May 3, 2024 04:00 PM ET
After-Market: $2.11 +0.03 (1.44%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: BMO |
3/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, Esperion Therapeutics (ESPR) reported earnings of -$0.50 per share, beating the Zacks Consensus Estimate of $-0.53 per share. This reflects a positive earnings surprise of 5.66%. Look out for ESPR's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 78.48%.
Earnings History
Price & Consensus
Zacks News for ESPR
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
ESPR: What are Zacks experts saying now?
Zacks Private Portfolio Services